Mohammed Alradhi

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 7

Top Topics

Neoadjuvant Chemotherapy

Mitochondrial Dna

Top Venues

Cancer medicine

Parkinson's disease

Therapeutic advances in urology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Alradhi, Mohammed Safi, Shenghua Tao, Abdullah Y Al-Danakh, Marwan Almoiliqy, Salem Baldi, Xiancheng Li
Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study. Therapeutic advances in urology 14 (2022)
Mohammed Alradhi, Shuang Wen, Mohammed Safi, Abdullah Y Al-Danakh, Honglong Wang, Abdullah Shopit, Min Sun, Bo Fan, Xiancheng Li
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer medicine (2022)
Mohammed Alradhi, Shuang Wen, Mohammed Safi, Abdullah Y Al-Danakh, Honglong Wang, Abdullah Shopit, Min Sun, Bo Fan, Xiancheng Li
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer medicine 12 (4) (2022)
Abdullah Y Al-Danakh, Mohammed Safi, Mohammed Alradhi, Marwan Almoiliqy, Qiwei Chen, Murad Al-Nusaif, Xuehan Yang, Aisha Al-Dherasi, Xinqing Zhu, Deyong Yang
Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinson's disease 2022 (2022)
Mohammed Alradhi, Shuang Wen, Mohammed Safi, Abdullah Y Al-Danakh, Honglong Wang, Abdullah Shopit, Min Sun, Bo Fan, Xiancheng Li
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer medicine 12 (4) (2022)
Mohammed Alradhi, Shuang Wen, Mohammed Safi, Abdullah Y Al-Danakh, Honglong Wang, Abdullah Shopit, Min Sun, Bo Fan, Xiancheng Li
Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer medicine 12 (4) (2022)
Abdullah Y Al-Danakh, Mohammed Safi, Mohammed Alradhi, Qiwei Chen, Salem Baldi, Xinqing Zhu, Deyong Yang
Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study. Cells 11 (22) (2022)